Article
Benchmarking UMI-aware and standard variant callers for low frequency ctDNA variant detection.
BMC genomics - 3 Sept 2024
Maruzani Rugare, Brierley Liam, Jorgensen Andrea, Fowler Anna
Abstract excerpt
BACKGROUND: Circulating tumour DNA (ctDNA) is a subset of cell free DNA (cfDNA) released by tumour cells into the bloodstream. Circulating tumour DNA has shown great potential as a biomarker to inform treatment in cancer patients. Collecting ctDNA is minimally invasive and reflects the entire genetic makeup of a patient's cancer. ctDNA variants in NGS data can be difficult to distinguish from sequencing and PCR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
